# Latin America Cardiac Resynchronization Therapy Study

Study · id `cardio:ct-nct01238874` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01238874](<https://clinicaltrials.gov/study/NCT01238874>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01238874

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01238874. Non-randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01238874, source copy `cardio:ctgov-nct01238874-2011-03-29`, retrieved 2026-10-26)
- Start date: 2011-02 (registry gives no type) (ClinicalTrials.gov record NCT01238874, source copy `cardio:ctgov-nct01238874-2011-03-29`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01238874, source copy `cardio:ctgov-nct01238874-2011-03-29`, retrieved 2026-10-26)
- Completion: 2014-12 (anticipated) (ClinicalTrials.gov record NCT01238874, source copy `cardio:ctgov-nct01238874-2011-03-29`, retrieved 2026-10-26)
- Countries: Mexico (ClinicalTrials.gov record NCT01238874, source copy `cardio:ctgov-nct01238874-2011-03-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01238874-2011-03-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Latin America Cardiac Resynchronization Therapy Study
- Acronym: LatAmCRT
- Condition: Heart Failure.
- Intervention (Device): Cardiac Resynchronization Therapy
- Lead sponsor: Medtronic Latin America
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 08b654b3388b910b3401d3b8699a717952916391662c9611f775fa1a80fdb4f1
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
